Amlodipine versus slow release Metoprolol in the treatment of Stable exertional Angina pectoris (AMSA)

Citation
K. Midtbo et P. Molstad, Amlodipine versus slow release Metoprolol in the treatment of Stable exertional Angina pectoris (AMSA), SC CARDIOVA, 34(5), 2000, pp. 475-479
Citations number
10
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
SCANDINAVIAN CARDIOVASCULAR JOURNAL
ISSN journal
14017431 → ACNP
Volume
34
Issue
5
Year of publication
2000
Pages
475 - 479
Database
ISI
SICI code
1401-7431(200010)34:5<475:AVSRMI>2.0.ZU;2-8
Abstract
Objectives-To compare the effects of amlodipine and slow release metoprolol on subjective symptoms and signs of ischaemia during bicycle ergometric ex ercise tests in patients with stable angina pectoris, Design-A randomized double-blind comparison of the two drugs in patients wi th documented coronary disease required to have at least three attacks of a ngina per week and to perform a symptom-limited exercise test with signific ant signs of ischaemia in the EGG. Results-Out of 127 patients, 117 completed the study, Both amlodipine and m etoprolol significantly increased total exercise time, total workload, time to onset of angina and time to 1 mm ST-depression with no significant diff erences between the drugs. Amlodipine was significantly more efficient than metoprolol in reducing ST-depression at maximum workload. Diary data revea led no differences in patients' self-rating of drug effects. Conclusions-Judged by suppression of subjective symptoms and performance on exercise tolerance tests amlodipine represents a useful alternative to met oprolol as monotherapy in stable angina pectoris.